The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Hengrui Medicine
Camrelizumab versus placebo combined with gemcitabine and cisplatin for recurrent or metastatic nasopharyngeal carcinoma: A randomized, double-blind, phase 3 trial.
 
Li Zhang
No Relationships to Disclose
 
Yunpeng Yang
No Relationships to Disclose
 
Song Qu
No Relationships to Disclose
 
Jin-Gao Li
Research Funding - Hengrui Medicine; Junshi Pharmaceuticals
 
Chaosu Hu
No Relationships to Disclose
 
Mingjun Xu
Research Funding - Hengrui Medicine
 
Weidong Li
No Relationships to Disclose
 
Ting Zhou
No Relationships to Disclose
 
Liangfang Shen
No Relationships to Disclose
 
Hui Wu
Consulting or Advisory Role - Hengrui Medicine
Research Funding - Hengrui Medicine
 
Jin Yi Lang
No Relationships to Disclose
 
Guangyuan Hu
No Relationships to Disclose
 
Zhanxiong Luo
No Relationships to Disclose
 
Zhichao Fu
No Relationships to Disclose
 
Shenhong Qu
No Relationships to Disclose
 
Ben Zhang
Employment - Hengrui Medicine
 
Qing Yang
Employment - Hengrui Medicine
 
Xiaojing Zhang
Employment - Hengrui Medicine
 
Jianjun Zou
No Relationships to Disclose
 
Wenfeng Fang
No Relationships to Disclose